Lead Oncology Imaging Biomarker Scientist (PET/CT)

Regeneron Pharmaceuticals, Inc.; New York (NY); Remote; USD 170.000 - 230.000; Vollzeit

Zusammenfassung

Regeneron Pharmaceuticals, Inc. is seeking a senior leader to drive the strategy and execution of imaging in oncology trials.

You will lead multimodality imaging endpoints and biomarker development across early and late‑phase studies, collaborating with clinical and external partners. They will require expertise in RECIST and related response criteria, as well as experience managing imaging CROs and regulatory interactions.

Qualifikationen

• Experience implementing central efficacy assessment using tumor response criteria (RECIST 1.1, PCWG3, Lugano, IMWG).
• Ability to lead imaging as a quantitative endpoint in oncology trials.

Aufgaben

• Formulate imaging biomarker strategies to inform Regeneron clinical pipeline.
• Lead design and implementation of multimodality imaging measures as trial endpoints.
• Collaborate with clinical teams as imaging SME to design protocols, manuals and analysis plans.
• Oversee imaging data integrity and CRO collaborations across studies.
• Serve as Imaging Scientific Lead for biomarker development in trials.
• Interface with regulators and ethics committees for imaging studies.

Kenntnisse

Oncology imaging

Imaging biomarkers

Clinical trial leadership

Regulatory engagement

PET imaging

Immuno-PET

CRO oversight

Ausbildung

PhD or MD

Jobbeschreibung

Regeneron Pharmaceuticals, Inc. is seeking a senior leader to drive the strategy and execution of imaging in oncology trials.

You will lead multimodality imaging endpoints and biomarker development across early and late‑phase studies, collaborating with clinical and external partners. They will require expertise in RECIST and related response criteria, as well as experience managing imaging CROs and regulatory interactions.